Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.
about
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors.Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer.Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerThe LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse modelMEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells
P2860
Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@ast
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@en
type
label
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@ast
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@en
prefLabel
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@ast
Combined MEK and Pi3'-kinase i ...... d cancer in vitro and in vivo.
@en
P2093
P2860
P50
P356
P1433
P1476
Combined MEK and Pi3'-kinase i ...... id cancer in vitro and in vivo
@en
P2093
Amandine Stooss
Dorothée Ruffieux-Daidié
Jürg Gertsch
Matthias A Roelli
Oussama ElMokh
P2860
P304
24604-24620
P356
10.18632/ONCOTARGET.15599
P407
P577
2017-04-01T00:00:00Z